retatrutide overdose June 8, 2026: Reckless physicians prescribing experimental, black market weight loss drugs: “Why are we waiting?” – Partnership for Safe Medicines Overdose risks increase as demand
Description
GLP-1 therapy can also be undertaken by people with obesity, insulin resistance or metabolic issues, even if they dont have diabetes
J Biol Chem (1984) 259(22):140827
This regulatory context applies broadly across the telehealth GLP-1 industry and is not specific to MEDVi
Furthermore, P9 binds to ICAM-2, acting as a GPCR-like signaling molecule to mediate GLP-1 secretion from L cells [97]
This risk is less for those who have had a same-day colonoscopy, have been on a day of clear liquids, and have taken a bowel prep, mitigating the risk
